Table 2 Correlation of clinical characteristcs of 234 gastric cancer patients with different expression of PSPH
Variables | PSPH expression | P | |
|---|---|---|---|
Low (n = 108) | High (n = 126) | ||
Age (years) | |||
 ≤ 59 | 59 (54.6) | 65 (51.6) |  |
 > 59 | 49 (45.4) | 61 (48.4) | 0.642 |
Gender | |||
 Male | 67 (62.0) | 85 (67.5) |  |
 Female | 41 (38.0) | 41 (32.5) | 0.386 |
Lauren classification | |||
 Intestinal-type | 23 (21.3) | 41 (32.5) |  |
 Diffuse-type | 70 (64.8) | 41 (32.5) |  |
 Mixed | 15 (13.9) | 44 (35.0) | < 0.001 |
Invasion depth | |||
 T1 | 21 (19.6) | 4 (3.2) |  |
 T2 | 7 (6.5) | 16 (12.8) |  |
 T3 | 41 (38.2) | 52 (41.6) |  |
 T4 | 38 (35.5) | 53 (42.4) | < 0.001 |
Lymph node metastasis | |||
 Negative | 32 (30.2) | 30 (24.6) |  |
 Positive | 74 (69.8) | 92 (75.4) | 0.343 |
Distant metastasis | |||
 Negative | 102 (94.4) | 106 (84.1) |  |
 Positive | 6 (5.6) | 20 (15.9) | 0.012 |
Stage | |||
 I + II | 47 (43.5) | 44 (35.2) |  |
 III + IV | 61 (56.5) | 81 (64.8) | 0.194 |